<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37619554</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1758-5090</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>Biofabrication</Title><ISOAbbreviation>Biofabrication</ISOAbbreviation></Journal><ArticleTitle>A scalable human iPSC-based neuromuscular disease model on suspended biobased elastomer nanofiber scaffolds.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">045020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1088/1758-5090/acf39e</ELocationID><Abstract><AbstractText>Many devastating neuromuscular diseases currently lack effective treatments. This is in part due to a lack of drug discovery platforms capable of assessing complex human neuromuscular disease phenotypes in a scalable manner. A major obstacle has been generating scaffolds to stabilise mature contractile myofibers in a multi-well assay format amenable to high content image (HCI) analysis. This study describes the development of a scalable human induced pluripotent stem cell (iPSC)-neuromuscular disease model, whereby suspended elastomer nanofibers support long-term stability, alignment, maturation, and repeated contractions of iPSC-myofibers, innervated by iPSC-motor neurons in 96-well assay plates. In this platform, optogenetic stimulation of the motor neurons elicits robust myofiber-contractions, providing a functional readout of neuromuscular transmission. Additionally, HCI analysis provides rapid and automated quantification of axonal outgrowth, myofiber morphology, and neuromuscular synapse number and morphology. By incorporating amyotrophic lateral sclerosis (ALS)-related TDP-43<sup>G298S</sup>mutant motor neurons and CRISPR-corrected controls, key neuromuscular disease phenotypes are recapitulated, including weaker myofiber contractions, reduced axonal outgrowth, and reduced number of neuromuscular synapses. Treatment with a candidate ALS drug, the receptor-interacting protein kinase-1 (RIPK1)-inhibitor necrostatin-1, rescues these phenotypes in a dose-dependent manner, highlighting the potential of this platform to screen novel treatments for neuromuscular diseases.</AbstractText><CopyrightInformation>Creative Commons Attribution license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheesbrough</LastName><ForeName>Aimee</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6955-0877</Identifier><AffiliationInfo><Affiliation>Centre for Gene Therapy &amp; Regenerative Medicine, Faculty of Life Sciences &amp; Medicine, King's College London, London SE1 9RT, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2PF, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harley</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6689-0227</Identifier><AffiliationInfo><Affiliation>Centre for Gene Therapy &amp; Regenerative Medicine, Faculty of Life Sciences &amp; Medicine, King's College London, London SE1 9RT, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riccio</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5577-2583</Identifier><AffiliationInfo><Affiliation>Centre for Gene Therapy &amp; Regenerative Medicine, Faculty of Life Sciences &amp; Medicine, King's College London, London SE1 9RT, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2PF, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8406-472X</Identifier><AffiliationInfo><Affiliation>UCL Centre for Biomaterials in Surgical Reconstruction and Regeneration, Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London NW3 2PF, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberam</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3539-3054</Identifier><AffiliationInfo><Affiliation>Centre for Gene Therapy &amp; Regenerative Medicine, Faculty of Life Sciences &amp; Medicine, King's College London, London SE1 9RT, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/M009513/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N025865/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N026063/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>108874/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT098503</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biofabrication</MedlineTA><NlmUniqueID>101521964</NlmUniqueID><ISSNLinking>1758-5082</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020724">Elastomers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057139" MajorTopicYN="Y">Nanofibers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020724" MajorTopicYN="N">Elastomers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR-Cas9</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">biobased elastomer nanofibers</Keyword><Keyword MajorTopicYN="N">high content image analysis</Keyword><Keyword MajorTopicYN="N">human induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">optogenetics</Keyword><Keyword MajorTopicYN="N">scalable neuromuscular disease modelling</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>18</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37619554</ArticleId><ArticleId IdType="pmc">PMC10478173</ArticleId><ArticleId IdType="doi">10.1088/1758-5090/acf39e</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr E M, Logroscino G, Robberecht W, Shaw P J, Simmons Z, van den Berg L H. Correction: amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17085. doi: 10.1038/nrdp.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth B, Karakaya M, Kye M J, Mendoza-Ferreira N. Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu. Rev. Genomics Hum. Genet. 2020;21:231. doi: 10.1146/annurev-genom-102319-103602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-102319-103602</ArticleId><ArticleId IdType="pubmed">32004094</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat. Rev. Dis. Primers. 2021;7:13. doi: 10.1038/s41572-021-00248-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-021-00248-3</ArticleId><ArticleId IdType="pubmed">33602943</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B M. Neuromuscular diseases. Semin. Neurol. 2016;36:409. doi: 10.1055/s-0036-1586263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1586263</ArticleId><ArticleId IdType="pubmed">27704495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L R, Culver D G, Tennant P, Davis A A, Wang M, Castellano-Sanchez A, Khan J, Polak M A, Glass J D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004;185:232. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor S, Zhang W, Delestree N, Remedio L, Mentis G Z, Burden S J. Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody. eLife. 2018;7:e34375. doi: 10.7554/eLife.34375.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34375</ArticleId><ArticleId IdType="pmc">PMC5837562</ArticleId><ArticleId IdType="pubmed">29460776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain. 2013;136:2359. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbach G D. Synapse formation between dissociated nerve and muscle cells in low density cell cultures. Dev. Biol. 1972;28:407. doi: 10.1016/0012-1606(72)90023-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0012-1606(72)90023-1</ArticleId><ArticleId IdType="pubmed">4338026</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles G B, Yohn D C, Wichterle H, Jessell T M, Rafuse V F, Brownstone R M. Functional properties of motoneurons derived from mouse embryonic stem cells. J. Neurosci. 2004;24:7848. doi: 10.1523/JNEUROSCI.1972-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1972-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729934</ArticleId><ArticleId IdType="pubmed">15356197</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeck J A, Choi S J, Mrejeru A, Ganat Y, Deisseroth K, Sulzer D, Mosharov E V, Studer L. Optogenetics enables functional analysis of human embryonic stem cell&#x2013;derived grafts in a Parkinson&#x2019;s disease model. Nat. Biotechnol. 2015;33:204. doi: 10.1038/nbt.3124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3124</ArticleId><ArticleId IdType="pmc">PMC5117952</ArticleId><ArticleId IdType="pubmed">25580598</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd Al Samid M, McPhee J S, Saini J, McKay T R, Fitzpatrick L M, Mamchaoui K, Bigot A, Mouly V, Butler-Browne G, Al-Shanti N. A functional human motor unit platform engineered from human embryonic stem cells and immortalized skeletal myoblasts. Stem Cells Cloning. 2018;11:85. doi: 10.2147/SCCAA.S178562.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/SCCAA.S178562</ArticleId><ArticleId IdType="pmc">PMC6233953</ArticleId><ArticleId IdType="pubmed">30519053</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper S T, Maxwell A L, Kizana E, Ghoddusi M, Hardeman E C, Alexander I E, Allen D G, North K N. C2C12 Co-culture on a fibroblast substratum enables sustained survival of contractile, highly differentiated myotubes with peripheral nuclei and adult fast myosin expression. Cell Motil. Cytoskelet. 2004;58:200. doi: 10.1002/cm.20010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cm.20010</ArticleId><ArticleId IdType="pubmed">15146538</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzel S G M, Platt R J, Subramanian V, Pearl T M, Rowlands C J, Chan V, Boyer L A, So P T C, Kamm R D. Microfluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor units. Sci. Adv. 2016;2:e1501429. doi: 10.1126/sciadv.1501429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1501429</ArticleId><ArticleId IdType="pmc">PMC4972469</ArticleId><ArticleId IdType="pubmed">27493991</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Uzel S G M, Kamm R D. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci. Adv. 2018;4:15. doi: 10.1126/sciadv.aat5847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aat5847</ArticleId><ArticleId IdType="pmc">PMC6179377</ArticleId><ArticleId IdType="pubmed">30324134</ArticleId></ArticleIdList></Reference><Reference><Citation>Maffioletti S M, et al. Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering. Cell Rep. 2018;23:899. doi: 10.1016/j.celrep.2018.03.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.091</ArticleId><ArticleId IdType="pmc">PMC5917451</ArticleId><ArticleId IdType="pubmed">29669293</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar M E, Abraha H Y, Bakooshli M A, Davoudi S, Thavandiran N, Tung K, Ahn H, Ginsberg H J, Zandstra P W, Gilbert P M. A 96-well culture platform enables longitudinal analyses of engineered human skeletal muscle microtissue strength. Sci. Rep. 2020;10:6918. doi: 10.1038/s41598-020-62837-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62837-8</ArticleId><ArticleId IdType="pmc">PMC7181829</ArticleId><ArticleId IdType="pubmed">32332853</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenburgh H, Shansky J, Benesch-Lee F, Barbata V, Reid J, Thorrez L, Valentini R, Crawford G. Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve. 2008;37:438. doi: 10.1002/mus.20931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20931</ArticleId><ArticleId IdType="pubmed">18236465</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar Bakooshli M, et al. A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction. eLife. 2019;8:e44530. doi: 10.7554/eLife.44530.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.44530</ArticleId><ArticleId IdType="pmc">PMC6516829</ArticleId><ArticleId IdType="pubmed">31084710</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado C B, et al. In vitro modeling of nerve&#x2013;muscle connectivity in a compartmentalized tissue culture device. Adv. Biosyst. 2019;3:1800307. doi: 10.1002/adbi.201800307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.201800307</ArticleId><ArticleId IdType="pmc">PMC6699992</ArticleId><ArticleId IdType="pubmed">31428672</ArticleId></ArticleIdList></Reference><Reference><Citation>Paredes-Redondo A, et al. Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections. Sci. Adv. 2021;7:eabi8787. doi: 10.1126/sciadv.abi8787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abi8787</ArticleId><ArticleId IdType="pmc">PMC8442926</ArticleId><ArticleId IdType="pubmed">34516770</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley P, Paredes-Redondo A, Grenci G, Viasnoff V, Lin Y Y, Lieberam I. 3D compartmentalised human pluripotent stem cell&#x2013;derived neuromuscular co-cultures. Bio-protocol. 2023;13:e4624. doi: 10.21769/BioProtoc.4624.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.4624</ArticleId><ArticleId IdType="pmc">PMC9993083</ArticleId><ArticleId IdType="pubmed">36908638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M, Andersson H, Martinsson S, Sabirsh A, Jonebring A, Wang Q D, Plowright A T, Drowley L. Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells. Sci. Rep. 2020;10:13575. doi: 10.1038/s41598-020-70547-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70547-4</ArticleId><ArticleId IdType="pmc">PMC7419298</ArticleId><ArticleId IdType="pubmed">32782331</ArticleId></ArticleIdList></Reference><Reference><Citation>Young J, Margaron Y, Fernandes M, Duchemin-Pelletier E, Michaud J, Flaender M, Lorintiu O, Degot S, Poydenot P. MyoScreen, a high-throughput phenotypic screening platform enabling muscle drug discovery. SLAS Discovery. 2018;23:790. doi: 10.1177/2472555218761102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2472555218761102</ArticleId><ArticleId IdType="pubmed">29498891</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheesbrough A, Sciscione F, Riccio F, Harley P, R&#x2019;Bibo L, Ziakas G, Darbyshire A, Lieberam I, Song W. Biobased elastomer nanofibers guide light-controlled human-iPSC-derived skeletal myofibers. Adv. Mater. 2022;34:e2110441. doi: 10.1002/adma.202110441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202110441</ArticleId><ArticleId IdType="pmc">PMC9131876</ArticleId><ArticleId IdType="pubmed">35231133</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley P, Neves G, Riccio F, Barcellos Machado C, Cheesbrough A, R&#x2019;Bibo L, Burrone J, Lieberam I. Pathogenic TDP-43 disrupts axon initial segment structure and neuronal excitability in a human iPSC model of ALS. bioRxiv Preprint. 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.16.492186</ArticleId></ArticleIdList></Reference><Reference><Citation>Re D B, et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron. 2014;81:1001. doi: 10.1016/j.neuron.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.011</ArticleId><ArticleId IdType="pmc">PMC3951532</ArticleId><ArticleId IdType="pubmed">24508385</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrell D K, Vanderslice E J, Lennon M L, Lyons A C, VeDepo M C, Jacot J G. Increasing salinity of fibrinogen solvent generates stable fibrin hydrogels for cell delivery or tissue engineering. PLoS One. 2021;16:e0239242. doi: 10.1371/journal.pone.0239242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239242</ArticleId><ArticleId IdType="pmc">PMC8133424</ArticleId><ArticleId IdType="pubmed">34010323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinds S, Bian W, Dennis R G, Bursac N. The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials. 2011;32:3575. doi: 10.1016/j.biomaterials.2011.01.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2011.01.062</ArticleId><ArticleId IdType="pmc">PMC3057410</ArticleId><ArticleId IdType="pubmed">21324402</ArticleId></ArticleIdList></Reference><Reference><Citation>Viola G, et al. Bioinspired multiresonant acoustic devices based on electrospun piezoelectric polymeric nanofibers. ACS Appl. Mater. Interfaces. 2020;12:34643&#x2013;57. doi: 10.1021/acsami.0c09238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.0c09238</ArticleId><ArticleId IdType="pmc">PMC7460092</ArticleId><ArticleId IdType="pubmed">32639712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Vissers M, et al. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: randomized, placebo&#x2010;controlled, double&#x2010;blind phase I/Ib studies in healthy subjects and patients. Clin. Transl. Sci. 2022;15:2010. doi: 10.1111/cts.13317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.13317</ArticleId><ArticleId IdType="pmc">PMC9372423</ArticleId><ArticleId IdType="pubmed">35649245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, et al. Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs. Stem Cell Rep. 2015;4:561. doi: 10.1016/j.stemcr.2015.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.02.010</ArticleId><ArticleId IdType="pmc">PMC4400613</ArticleId><ArticleId IdType="pubmed">25801509</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton S K, et al. TDP-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell model. Brain Commun. 2021;3:fcab255. doi: 10.1093/braincomms/fcab255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab255</ArticleId><ArticleId IdType="pmc">PMC8936427</ArticleId><ArticleId IdType="pubmed">35350711</ArticleId></ArticleIdList></Reference><Reference><Citation>Thielicke W, Stamhuis E J. PIVlab&#x2014;towards user-friendly, affordable and accurate digital particle image velocimetry in MATLAB. J. Open Res. Softw. 2014;2:30. doi: 10.5334/jors.bl.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/jors.bl</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>